ProCE Banner Activity

From HIVR4P // Virtual 2021, Investigational Strategies for Expanding PrEP Options

Conference Coverage
Clinical Thought
Read my take on promising new data from HIVR4P // Virtual 2021 on broadly neutralizing HIV antibody immunoprophylaxis and multipurpose prevention technologies under investigation for HIV prevention.

Released: February 18, 2021

Expiration: February 17, 2022

No longer available for credit.

Share

Faculty

Kenneth Mayer

Kenneth Mayer, MD

Infectious Disease Attending
Beth Israel Deaconess Medical Center
Professor of Medicine
Harvard Medical School
Medical Research Director
Fenway Community Health
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare

Partners

IAS 2018

ProCE Banner

IAS 2021 HIV R4P

ProCE Banner

Faculty Disclosure

Primary Author

Kenneth Mayer, MD

Infectious Disease Attending
Beth Israel Deaconess Medical Center
Professor of Medicine
Harvard Medical School
Medical Research Director
Fenway Community Health
Boston, Massachusetts

Kenneth Mayer, MD, has disclosed that he has received consulting fees from Gilead Sciences and Merck and funds for research support from Gilead Sciences, Janssen, and Merck.